Natural Health Trends Corp 4Q 2025 Earnings Call - Restructuring Sets Stage for Profitability, $1.5M Annualized Savings Expected in 2026
Summary
Natural Health Trends reported a mixed 4th Quarter, with revenue of $9.7 million, up 3% sequentially but down 10% year-over-year. Management pointed to stability returning in parts of the business, with reorders as a share of total orders rising in its largest market, Q-rated product bundle sales up 10% for the year, and pockets of strength in Taiwan, Peru, Japan, and Colombia. Gross margin slipped to 72.9% mainly because of inventory write-offs tied to discontinued products and the shift of manufacturing out of the U.S., though management says margin would be comparable to last year without those charges.
The company is finishing a restructuring program intended to cut costs and simplify supply chains, including relocating about 40% of sourcing to East Asia. Management expects most of the roughly $1.5 million in annualized savings to materialize in 2026. Near-term pain is visible: a $635,000 operating loss in the quarter, net loss of $588,000, cash used in operations of $959,000 in Q4 and $6.0 million for the year, and $9.2 million in dividends paid during 2025. The board still declared a $0.10 quarterly dividend payable February 27. The 25th anniversary campaign, centered on a large Hong Kong event, is presented as a marketing catalyst, but execution and cash consumption will be watched closely as the company pursues a path back to profitability.
Key Takeaways
- 4th Quarter revenue $9.7 million, up 3% sequentially from Q3 2025, down 10% year-over-year from Q4 2024 ($10.8 million).
- Full year showed signs of stabilization beginning in April, with reorders as a percent of total orders increasing in the largest market, and Q-rated product bundle sales rising 10% for the year.
- Gross profit margin was 72.9% in Q4, down from 74.2% year-over-year, driven by write-offs of components inventory tied to discontinued products and manufacturing transitions out of the U.S.; management says margin would be comparable excluding those write-offs.
- Commissions declined as a percentage of net sales to 40.3% in Q4 from 41.9% a year ago, reflecting modest improvement in distribution economics.
- SG&A was $3.8 million in Q4, roughly flat year-over-year; SG&A would have fallen 8% absent $208,000 of restructuring-related charges recognized in the quarter.
- Operating loss was $635,000 in Q4; excluding $283,000 of restructuring-related charges, operating loss would have been $352,000.
- Net loss for Q4 was $588,000, or $0.05 per diluted share, versus net income of $176,000, or $0.02 per diluted share, in Q4 2024.
- Cash used in operating activities was $959,000 in Q4 and $6.0 million for full year 2025; excluding a required annual tax installment tied to the 2017 U.S. Tax Cuts and Jobs Act, cash used was $943,000 for the year.
- Total cash, cash equivalents, and marketable securities were $28.9 million at December 31, down from $32.0 million at September 30, after dividend payments and operating cash use.
- The board prioritized returning capital, paying $9.2 million in dividends in 2025 and declaring a $0.10 quarterly dividend on Feb 2, payable Feb 27, despite the recent cash burn.
- Restructuring initiatives are substantially complete, including relocation of roughly 40% of product sourcing from America to East Asia to reduce tariff risk and streamline logistics.
- Management expects to realize a significant portion of approximately $1.5 million annualized cost savings during 2026, positioning the company toward profitability if trends hold.
- Company invested in a new back-office system during the quarter, contributing to cash outflows tied to implementation and restructuring.
- Geographic performance was mixed but improving: Taiwan and Peru showed encouraging growth in Q4, while Japan and Colombia posted strong gains for the year.
- Management is promoting a 25th anniversary program as a demand catalyst, including a 1,500-person Hong Kong event, anniversary products, and member incentives; this is a potential marketing tailwind but will consume resources and requires execution.
Full Transcript
Conference Operator: day and welcome to the Natural Health Trends Corp. 4th Quarter 2025 earnings conference call. At this time, I would like to turn the conference over to Michelle Glidewell with Natural Health Trends Corp.
Michelle Glidewell, Unspecified, Natural Health Trends Corp: Thank you, and welcome to Natural Health Trends 4th Quarter and Full Year 2025 earnings conference call. During today’s call, there may be statements made relating to the future results of the company that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results, performance, or achievements can differ materially from those anticipated in such forward-looking statements through the result of certain factors, including those set forth in the company’s filings with the Securities and Exchange Commission. It should also be noted that a replay of today’s call can be found on the investor section of the company’s corporate website at naturalhealthtrendscorp.com. At this time, I’d like to turn the call over to Chris Sharng, President of Natural Health Trends.
Chris Sharng, President, Natural Health Trends Corp: Thank you, Michelle, and thanks to everyone for joining us this morning to discuss our 4th Quarter and Full Year 2025 financial results. With me today is Scott Davidson, our Senior Vice President and Chief Financial Officer. In the 4th Quarter, we delivered a 3% sequential increase in revenue over the preceding 3rd Quarter. Meanwhile, our Full Year performance is more balanced than it may appear, as we saw glimpses of stability and rebound starting in April. For example, in our largest market, reorders as a percent of total orders increased compared to 2024, and sales of our Q-rated product bundles rose 10% for the Full Year. These trends reflect continued member engagement and ongoing demand for our core products. We also saw encouraging growth in the 4th Quarter in Taiwan and Peru. Moreover, Japan and Colombia achieved strong increases all year.
During the quarter, we continue to take actions to improve the efficiency and strength of our operations. Restructuring initiatives announced last quarter are substantially complete, including the relocation of about 40% of our product sourcing from America to East Asia in order to reduce tariff uncertainty and streamline logistics. Also included are measures to optimize our workforce and downsize several offices. From these actions, we expect to realize a significant portion of the associated $1.5 million annualized cost savings during 2026. 2026 represents an important milestone for the company as we celebrate our 25th anniversary. We have prepared exciting programs that include a big celebration event in Hong Kong, where we anticipate 1,500 attendees, signature products for the anniversary, and incentives to leverage these special moments. We expect a catalyst for renewed momentum across our products and our business.
As I close, I want to sincerely thank our leaders, members, preferred customers, employees, and stockholders. Your commitment is foundational to NHT Global’s long-term success, and it directly supports the global reach and impact of our products. NHT Global continues to offer opportunities for people of all backgrounds, whether they seek to supplement income, build a business, or take a more proactive approach to health and wellness. With a strong product portfolio and a renewed focus on execution, we are confident in our ability to support these goals in an evolving global environment. As we welcome the Year of the Horse, we extend our best wishes for health, prosperity, and success throughout 2026. Now I’ll pass the call to our CFO, Scott Davidson, who will share a detailed review of our financial results. Scott?
Scott Davidson, Senior Vice President and Chief Financial Officer, Natural Health Trends Corp: Thank you, Chris. Fourth Quarter revenue of $9.7 million increased 3% compared to $9.5 million in the 3rd Quarter of 2025, and declined 10% compared to $10.8 million in the 4th Quarter of last year. Revenue in our primary market of Greater China increased 2% compared to the 3rd Quarter, and was supplemented by improvement in other markets, particularly Taiwan and Peru. Gross profit margin was 72.9% in the 4th Quarter compared with 74.2% in the 4th Quarter of last year due to the write-off of components inventory related to discontinued products and products whose manufacturing has transitioned outside the United States. Gross profit margin would be comparable to last year without these write-offs. Commissions expenses as a percent of net sales for the 4th Quarter was 40.3% compared with 41.9% a year ago.
Selling general and administrative expenses were $3.8 million for the 4th Quarter compared with $3.9 million a year ago. SG&A would have declined by $309,000, or 8% year-over-year if not for the $208,000 of restructuring-related charges recognized in SG&A during the quarter. As a result, operating loss for the quarter was $635,000 compared to $421,000 in the 4th Quarter of last year. Excluding $283,000 of restructuring-related charges recognized in cost of sales in SG&A during the 4th Quarter, operating loss would have been $352,000 during the quarter. Net loss for the 4th Quarter was $588,000, or $0.05 per diluted share, compared to net income of $176,000, or $0.02 per diluted share in the 4th Quarter of 2024. Despite the loss before income taxes in the 4th Quarter this year, tax expense of $175,000 was recognized during the quarter due to an increase in foreign tax expense.
Now I’ll turn to our cash flows and balance sheet. Net cash used in operating activities was $959,000 during the 4th Quarter of this year, primarily due to the restructuring-related activities and payments related to our new back-office system implementation. For the full year, net cash used in operating activities was $6 million, compared to $3.4 million a year ago. Excluding our required annual tax installment payment related to the 2017 U.S. Tax Cuts and Jobs Act, we used $943,000 in cash from operations during 2025. Total cash, cash equivalents, and marketable securities were $28.9 million at December 31st, down from $32 million at September 30th due to our quarterly dividend payment and the cash used in operations during the quarter. For the full year of 2025, we paid out $9.2 million in dividends.
As returning capital to our stockholders remains a priority, I am pleased to announce that on February 2nd, our board of directors declared a quarterly cash dividend of $0.10 per share, which will be payable on February 27th to stockholders of record as of February 17th. In closing, I’m pleased with the progress we were able to make during the 4th Quarter, as our restructuring initiatives are substantially complete. Looking forward, we can expect to realize a significant portion of the approximately $1.5 million in cost savings during 2026, which positions the business on a clear path towards profitability and improved performance. As we enter our 25th anniversary year, we view this milestone as both a celebration of our legacy and a foundation for our future.
We believe it will be a special and engaging year to be a part of our business, and we look forward to making it meaningful and rewarding for our global community. That completes our prepared remarks. I will now turn the call back over to the operator.
Conference Operator: This does conclude today’s call. Thank you for your participation. You may now disconnect.
